Concepedia

Sara Murdock

SM

Statistics

Publications

3

Citations

167

H-Index

3

Active since

2015

Affiliations

AbbVie (United States)(Current)

Sara Murdock is an author at AbbVie (United States) specializing in pharmacology, btk inhibitors, and hit-to-lead optimization.

Publications per year

2015–2018

3

Publications

3

Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol

Eric R. Goedken, M.A. Argiriadi, David Banach et al. · Journal of Biological Chemistry · 2015 · 96 citations · Full text

, , +12

ABBV-105, a selective and irreversible inhibitor of Bruton’s tyrosine kinase, is efficacious in multiple preclinical models of inflammation

Christian Goess, Christopher M. Harris, Sara Murdock et al. · Modern Rheumatology · 2018 · 38 citations

, , +17

Merits and Pitfalls in the Characterization of Covalent Inhibitors of Bruton’s Tyrosine Kinase

Christopher M. Harris, Sage E. Foley, Eric R. Goedken et al. · SLAS DISCOVERY · 2018 · 33 citations · Full text

, , +17

1–3 of 3